AQP3 and irritable bowel syndrome: Current progress has indicated that AQP3 may act an important target for the disorders that involve disruption of intestinal fluid homeostasis (as summarized in Figure 2, created with BioRender.com), such as diarrhea, constipation, inflammatory bowel disease, and irritable bowel syndrome.